Aim: On the background of reports concerning harm to the health of users of a contraceptive product, the paper aims at emphasizing the manufacturers' responsibility to warrant safe use of contraceptive pills and devices.
Method:The method consists in an analysis of sources of information commonly used by women and their healthcare providers, ie, "information for use" provided by manufacturers and statements by renowned agencies, such as WHO, FDA, National Center for Health Research, and CDC. Also, research publications in scholarly journals are critically analysed.Results: Presently, women do not receive information necessary for the safe use of contraceptive pills and devices --neither from all pharmaceutical companies nor from healthcare providers.
Conclusion:Comprehensive, complete, and reliable information on all available methods of contraception is difficult to obtain. Pharmaceutical companies should be obliged by law to inform the users of their products in a comprehensible manner about all risks and potential complications without using a confusing, deceptive, or misleading vocabulary.
MaterialsMaterial used comprises primarily information provided by manufacturers in packaging labels and by the FDA in various publications. In instances where it seems appropriate, pertinent scholarly articles published in the most prestigious professional journals are critically analysed.
MethodsThe method consists in an analysis of information provided by various sources, such as manufacturers, FDA, scholarly articles, and popularizing publications emanating from academic institutions and clinics. This information is assessed by analyzing the nomenclature used and by evaluating the reliability of data presented. Criteria applied are principles of evidence-based research.